In turn, conflicting studies performed in postmortem brain tissues from individuals with AD have shown BDNF mRNA levels either decreased in the neocortex and in the Meynert nucleus basalis—where cholinergic innervation of the cerebral cortex are mostly present [91,92,93]—or increased in the hippocampus [94,95]. This evidence concerns the gene BDNF and Alzheimer disease.